Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/22/2011 | US20110312890 Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements |
12/22/2011 | US20110312883 Neurturin molecules |
12/22/2011 | US20110312881 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases |
12/22/2011 | US20110312879 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
12/22/2011 | US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
12/22/2011 | US20110312874 Use of a trpc channel for the treatment of a cardiovascular disease |
12/22/2011 | US20110312873 N-terminally modified tetrapeptide derivatives having a c-terminal arginine mimetic |
12/22/2011 | US20110312872 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
12/22/2011 | US20110311653 Use of nitrite salts in chronic ischemia |
12/22/2011 | US20110311652 Novel Saponin Compounds, Methods of Preparation Thereof, Use Thereof and Pharmaceutical Compositions |
12/22/2011 | US20110311628 Pulsatile release composition of therapeutic agent |
12/22/2011 | US20110311626 Controlled release compositions comprising anti-cholinergic drugs |
12/22/2011 | US20110311620 Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors |
12/22/2011 | US20110311546 Angiopoietin-2 specific binding agents |
12/22/2011 | US20110311538 Inhibitors of receptor tyrosine kinases and methods of use thereof |
12/22/2011 | US20110311532 Inhibition of complement and cellular activation |
12/22/2011 | US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
12/22/2011 | US20110311530 Truncated baff receptors |
12/22/2011 | US20110311517 Antibodies and methods for treating estrogen receptor-associated diseases |
12/22/2011 | US20110311504 Coenzyme q10-containing composition for oral ingestion |
12/22/2011 | US20110311493 Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates |
12/22/2011 | US20110311491 Treatment of sarcoidosis using placental stem cells |
12/22/2011 | US20110311486 1,2,4-oxadiazole benzoic acid compositions |
12/22/2011 | US20110311483 Crth2 modulators |
12/22/2011 | US20110311452 Inflammation targeting particles |
12/22/2011 | US20110311451 Synthesis of polymer conjugates of indolocarbazole compounds |
12/22/2011 | US20110311448 Antibody to rage and uses for in vivo imaging or for targeting therapy |
12/22/2011 | CA2802918A1 Process for the preparation of dronedarone |
12/22/2011 | CA2802535A1 Thioacetate compounds, compositions and methods of use |
12/22/2011 | CA2802526A1 Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof |
12/22/2011 | CA2802483A1 Crystal of amide compound |
12/22/2011 | CA2802441A1 Use of isoacteoside or pharmaceutically acceptable salt thereof |
12/22/2011 | CA2801707A1 Ranolazine for use for the treatment of pulmonary hypertension |
12/22/2011 | CA2794731A1 Anti-axl antibodies and methods of use |
12/21/2011 | EP2397551A1 Compounds and methods for modulating expression of PCSK9 |
12/21/2011 | EP2397494A1 Human antibodies that bind human TNFalpha |
12/21/2011 | EP2397481A1 Inhibitor of casein kinase 1delta and casein kinase 1epsilon |
12/21/2011 | EP2397473A1 A stable highly crystalline anacetrapib |
12/21/2011 | EP2397462A2 Compounds, compositions and methods of treatment for heart failure |
12/21/2011 | EP2397150A1 Biopolymer, implant comprising it and uses thereof |
12/21/2011 | EP2397142A2 Use of dpp iv inhibitors |
12/21/2011 | EP2397129A1 Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
12/21/2011 | EP2396343A2 Modified virus vectors and methods of making and using the same |
12/21/2011 | EP2396001A1 Par-1 antagonism in fed or antacid-dosed patients |
12/21/2011 | EP2396000A1 Combination vegfr2 therapy with temozolomide |
12/21/2011 | EP2395838A1 Stable pharmaceutical composition for atherosclerosis |
12/21/2011 | EP1966139B1 Aspartic protease inhibitors |
12/21/2011 | EP1926729B1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
12/21/2011 | EP1893634B1 Pyrimidine derivatives and their use as p2y12 receptor antagonists |
12/21/2011 | EP1832584B1 Pyrimidinylisoxazole derivative |
12/21/2011 | EP1804789B1 Method of treating human preeclampsia employing resibufagenin |
12/21/2011 | EP1664769B1 Assay for detecting atrial and brain natriuretic peptide prohormones |
12/21/2011 | EP1534290B1 Novel inhibitors of kinases |
12/21/2011 | EP1507855B1 Elongase genes and uses thereof |
12/21/2011 | EP1454142B1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
12/21/2011 | EP1326841B1 Pyridinone derivatives for treatment of atherosclerosis |
12/21/2011 | CN1997369B 阿片样受体拮抗剂化合物在制备治疗和/或预防对抑制靶向钙调神经磷酸酶敏感的皮肤病的药物中的应用 Preparation of opioid receptor antagonist treatment and / or prevention of the targeted inhibition of the enzyme calcineurin-sensitive dermatological medicament compound |
12/21/2011 | CN1951432B 参附组合物、制剂及其制备方法和用途 Shenfu composition and its preparation method and use |
12/21/2011 | CN1879653B 牛黄纳米粉制备工艺及其药物制剂 Bezoar nanopowder technology and pharmaceutical preparations |
12/21/2011 | CN1738817B 玻璃体结合蛋白受体的新的拮抗剂衍生物,它们的制备方法,它们作为药物的应用和包含它们的药物组合物 Vitronectin receptor antagonists new derivatives, processes for their preparation, their use as medicaments and pharmaceutical compositions containing them |
12/21/2011 | CN102292341A 对apo a有活性的噻吩并三唑并二氮杂*衍生物 Active against apo a thieno-triazolo-diaza derivative * |
12/21/2011 | CN102292333A 蛋白激酶c抑制剂及其用途 C protein kinase inhibitors and their use |
12/21/2011 | CN102292124A 用于治疗急性心肌梗死和相关疾患的方法 The method of treatment of acute myocardial infarction and related diseases for |
12/21/2011 | CN102292091A 用于预防和治疗动脉硬化的组合物 Compositions for the prevention and treatment of atherosclerosis |
12/21/2011 | CN102292084A 包含氨氯地平和氯沙坦的固体药物组合物 Contains amlodipine and losartan solid pharmaceutical composition |
12/21/2011 | CN102292070A 具有提高的稳定性的包含氨氯地平和氯沙坦的固体药物组合物 Having improved stability of a solid pharmaceutical composition comprising amlodipine and losartan |
12/21/2011 | CN102286586A 一种蛇肉低聚肽的制备方法 Preparation of a snake oligopeptide |
12/21/2011 | CN102286425A 使骨髓间充质干细胞靶向于心肌梗死灶的培养基及其制备方法 Culture medium and preparation method of mesenchymal stem cells in myocardial infarction targeted |
12/21/2011 | CN102286334A 草莓葛根酒及其制备方法 Kudzu strawberry wine and its preparation method |
12/21/2011 | CN102286323A 一种活血化瘀酒的酿造方法 A blood circulation method of brewing wine |
12/21/2011 | CN102286314A 一种保健红葡萄酒 A health red wine |
12/21/2011 | CN102286054A Cyclovirobuxinum D derivatives and preparation method and use thereof |
12/21/2011 | CN102285996A 一种苯磺酸氯吡格雷晶型Ⅱ及其制备方法和用途 One kind of p-type Ⅱ clopidogrel and its preparation method and use |
12/21/2011 | CN102285978A 一种制备含有苯并呋咱环类抗高血压药物的合成方法 An Benzofurazan ring class of antihypertensive drugs containing synthetic methods |
12/21/2011 | CN102285962A Phenoxy alkyl piperazine compounds, preparation method thereof and medicinal use thereof |
12/21/2011 | CN102285951A 木犀草素衍生物及其预防和治疗心血管疾病的用途 Luteolin derivatives and their use in the prevention and treatment of cardiovascular disease |
12/21/2011 | CN102285948A 四羟基苯并吡喃酮类化合物及其用途 Four hydroxybenzo Pyrones their uses |
12/21/2011 | CN102285916A 匹伐他汀钙的晶形 Pitavastatin calcium crystal form |
12/21/2011 | CN102284060A 窦房结I<sub>f</sub>当前抑制剂和血管紧张素转化酶抑制剂的组合在治疗心力衰竭中的用途 Sinus I <sub> f </ sub> current inhibitors and angiotensin converting enzyme inhibitors in the treatment of heart failure in combination use |
12/21/2011 | CN102284017A 一种降高血压的中药制剂 A Reduced hypertension Chinese medicine |
12/21/2011 | CN102284004A 一种治疗心律失常的药剂 A method of treating arrhythmia agents |
12/21/2011 | CN102283985A 一种枳实薤白桂枝汤整合型新剂型制备技术 One kind of citrus aurantium Xiebai Guizhi decoction preparation of new formulations of integrated technologies |
12/21/2011 | CN102283984A 一种瓜蒌薤白白酒汤整合型新剂型制备技术 One kind of white wine soup Gualouxiebai integrated new formulation preparation techniques |
12/21/2011 | CN102283953A 一种中药组合痔疮药 Combination of a traditional Chinese medicine hemorrhoid medicine |
12/21/2011 | CN102283943A 一种四妙勇安汤整合型新剂型制备技术 One kind of soup Simiao integrated new formulation preparation techniques |
12/21/2011 | CN102283940A 一种治疗心悸的中药制剂 A treatment of Chinese medicine palpitations |
12/21/2011 | CN102283939A 一种治疗高血压的中药制剂及其制备方法 A high blood pressure medicine and its preparation method of treatment |
12/21/2011 | CN102283930A 一种治疗脉管炎的中药酊剂 A treatment for vasculitis herbal tinctures |
12/21/2011 | CN102283919A 一种治疗中风的中药复方制剂及制作方法 A stroke of traditional Chinese medicine and production methods of treatment |
12/21/2011 | CN102283914A 一种治疗多种风湿病的中药膏 A method for treating a variety of rheumatism ointment |
12/21/2011 | CN102283911A 治疗缺血性中风的益气活血风静胶囊 Treatment of ischemic stroke Yiqihuoxue calm wind Capsules |
12/21/2011 | CN102283909A 治疗肛肠疾病、肥胖、高脂血症、痤疮的药物及其应用 Treatment of anorectal disease, obesity, hyperlipidemia, acne medications and Its Applications |
12/21/2011 | CN102283871A 诃子树皮中活性成分、其提取方法及用途 Terminalia bark of the active ingredient, its extraction methods and uses |
12/21/2011 | CN102283870A 一种高纯度银杏叶组合物,含其制剂及其制备方法 Ginkgo biloba high purity compositions containing it and its preparation method |
12/21/2011 | CN102283864A 阿胶泡腾片及其制备方法 Gelatin effervescent tablet and its preparation method |
12/21/2011 | CN102283844A 含有克拉维酸的药物组合物及其用途 Clavulanic acid containing pharmaceutical compositions and use thereof |
12/21/2011 | CN102283836A 索拉非尼在治疗蛛网膜下腔出血后发生的早期脑损伤的应用 Application of early brain injury after sorafenib treatment of subarachnoid hemorrhage |
12/21/2011 | CN102283834A 一种含奥利司他的药物组合物及用途 Containing orlistat pharmaceutical compositions and uses |
12/21/2011 | CN102283832A 一种预防或治疗高血压肥胖患者的药物组合物及用途 A method of preventing or treating hypertension in obese patients a pharmaceutical composition and use |
12/21/2011 | CN102283831A 一种治疗冠心病的西药复方及用途 A treatment for coronary heart disease and use western medicine |